<?xml version="1.0" encoding="UTF-8"?>
<ref id="B66">
 <label>66.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rivero-Calle</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Raguindin</surname>
    <given-names>PF</given-names>
   </name>
   <name>
    <surname>Gomez-Rial</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Rodriguez-Tenreiro</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Martinon-Torres</surname>
    <given-names>F</given-names>
   </name>
  </person-group>
  <article-title>Meningococcal group B vaccine for the prevention of invasive meningococcal disease caused by 
   <italic>Neisseria Meningitidis</italic> serogroup B. 
   <italic>Infect Drug Resist</italic>
  </article-title>. (
  <year>2019</year>) 
  <volume>12</volume>:
  <fpage>3169</fpage>â€“
  <lpage>88</lpage>. 
  <pub-id pub-id-type="doi">10.2147/IDR.S159952</pub-id>
 </mixed-citation>
</ref>
